Jane Street Group LLC Acquires Shares of 26,208 Septerna, Inc. (NASDAQ:SEPN)

Jane Street Group LLC acquired a new position in shares of Septerna, Inc. (NASDAQ:SEPN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 26,208 shares of the company's stock, valued at approximately $600,000. Jane Street Group LLC owned 0.06% of Septerna as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. TRV GP V LLC bought a new stake in shares of Septerna in the fourth quarter valued at approximately $142,337,000. TRV GP VI LLC bought a new stake in Septerna during the fourth quarter worth $72,191,000. Samsara BioCapital LLC bought a new position in shares of Septerna in the 4th quarter valued at $63,399,000. Avoro Capital Advisors LLC bought a new position in Septerna in the fourth quarter valued at about $25,419,000. Finally, Vanguard Group Inc. bought a new position in shares of Septerna in the fourth quarter worth about $22,557,000.

Insider Activity at Septerna

In related news, Director Alan Ezekowitz acquired 41,355 shares of the company's stock in a transaction on Thursday, March 6th. The shares were acquired at an average cost of $6.00 per share, for a total transaction of $248,130.00. Following the purchase, the director now owns 104,101 shares in the company, valued at approximately $624,606. The trade was a 65.91% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. 4.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several brokerages recently commented on SEPN. Wells Fargo & Company increased their price objective on shares of Septerna from $11.00 to $18.00 and gave the company an "equal weight" rating in a research note on Friday, May 16th. Cantor Fitzgerald boosted their price objective on Septerna from $20.00 to $25.00 and gave the stock an "overweight" rating in a research report on Friday, May 16th.

Septerna Price Performance

Shares of SEPN stock traded up $0.14 during trading hours on Thursday, hitting $9.86. 431,444 shares of the company's stock traded hands, compared to its average volume of 711,475. The stock's 50 day simple moving average is $6.93 and its 200 day simple moving average is $13.48. Septerna, Inc. has a 12 month low of $4.17 and a 12 month high of $28.99.

Septerna (NASDAQ:SEPN - Get Free Report) last released its earnings results on Thursday, May 15th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.38) by ($0.11). The company had revenue of $0.22 million for the quarter. As a group, equities analysts expect that Septerna, Inc. will post -7.11 EPS for the current year.

Septerna Company Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.